NCT02390297

Long Term Follow up for the Detection of Delayed Adverse Events in Cal-1 Recipients

Long Term Follow-up for the Detection of Delayed Adverse Events in Recipients of CD4+ T Lymphocytes and/or CD34+ Hematopoietic Stem/Progenitor Cells Transduced With LVsh5/C46, a Dual Anti-HIV Gene Transfer Construct

• Status: Active Not Recruiting
• Phase: —
• Study type: Observational
• Enrollment: 11 (actual)
• Sponsor: Calimmune, Inc. · Industry
• Sex: All
• Age: —
• Healthy volunteers: Not accepted

Summary

Long term safety follow-up of Cal-1 recipients

Detailed description

Long Term Follow-up for the Detection of Delayed Adverse Events in Recipients of CD4+ T Lymphocytes and/or CD34+ Hematopoietic Stem/Progenitor Cells Transduced with LVsh5/C46 (Cal-1), a Dual Anti-HIV Gene Transfer Construct

Conditions

• HIV-1 Infection
• Receipt of Cal-1 Modified Hematopoietic Cellular Products

Interventions

Type	Name	Description
GENETIC	Blood tests	Collection of blood samples for general health (complete blood count) and Cal-1 specific analyses

Timeline

• Start date: 2015-04-01
• Primary completion: 2031-10-01
• Completion: 2031-10-01
• First posted: 2015-03-17
• Last updated: 2025-10-10

Locations

2 sites across 1 country: United States